Concepedia

Alain Luxembourg

AL

Statistics

Publications

58

Citations

4.5K

H-Index

33

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Moffitt Cancer Center

Medical University of Vienna

Ichor Medical Systems (United States)

University of Copenhagen

Alain Luxembourg is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and vaccination.

Top concepts

Publications per year

1987–2023

58

Publications

58

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Elmar A. Joura, Anna R. Giuliano, Ole‐Erik Iversen et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Warner K. Huh, Elmar A. Joura, Anna R. Giuliano et al. · The Lancet · 2017 · 448 citations · Full text

, , +11

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

Ole‐Erik Iversen, María J. Miranda, Àngels Ulied et al. · JAMA · 2016 · 197 citations

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

Susanne K. Kjær, Mari Nygård, Karin Sundström et al. · EClinicalMedicine · 2020 · 182 citations · Full text

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Elmar A. Joura, Kevin A. Ault, F. Xavier Bosch et al. · Cancer Epidemiology Biomarkers & Prevention · 2014 · 179 citations · Full text

1–5 of 58